|
Post 5-alpha-reductase inhibitor treatment syndrome (disorder)
Post 5-alpha-reductase inhibitor treatment syndrome
A rare neurologic disease characterized by persistent side effects of terminated 5-alpha-reductase inhibitor treatment, including impaired sexual function (low libido, erectile dysfunction, diminished semen volume and force), genital numbness or paresthesia, gynecomastia, depression, brain fog and elevated anxiety. Additional symptoms may include muscular problems (tics, muscle spasms, tremors, involuntary muscle contraction and muscular ache), joint pain, chronic fatigue, migraine, decreased body temperature and dry skin.
Id1373752007
StatusPrimitive
SNOMED CT to ICD-10 extended map
TargetG97.8
RuleTRUE
AdviceALWAYS G97.8 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
CorrelationSNOMED CT source code to target map code correlation not specified
TargetY42.6
RuleTRUE
AdviceALWAYS Y42.6
CorrelationSNOMED CT source code to target map code correlation not specified